PsyCan Welcomes Bill C-286, Thomas’ Bill, to Create a Clearer Regulated Pathway for Medical Psilocybin Access
AI Summary
PsyCan applauds the introduction of Bill C-286, which aims to establish a more defined regulatory framework for medical psilocybin use in Canada. This move is crucial as it seeks to streamline access while maintaining the oversight of Health Canada’s drug-approval process. As psychedelics gain recognition for their potential therapeutic benefits, this bill could significantly influence the future landscape of mental health treatment in the country.
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.